TUBB2A and breast cancer: Using reverse-phase (RP)-nLC-ESI-MS/MS analysis, Shin et al. showed that tubulin beta-2A chain (TUBB2A) may be considered as a biomarker for the prediction of distant metastatic BC, based on this high expression in highly invasive BC cell lines [63].